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ABSTRACT 
In the present study it was aimed determine the in vitro antileishmanial activity of Berberis vulgaris L. 
against Leishmania tropica promastigotes. The aerial parts of Berberisvulgariswere collected from 
Spil Mountain, Manisa.The ethanolic extract of the plant material was prepared. The consecutive 
concentrations of the plant extract (25-100µg/ml) were set for in vitro antileishmanial assays. In 
addition to in vitroinhibitory activities against Leishmania tropica promastigotes, the cytotoxicity of 
the plant extract was also measured by WST-1 Cell proliferation assay. The percentages of parasite 
inhibition in the presence of B. vulgaris ethanol extract in comparison with glucantime reference 
group at time interval of 12-72 hours were observed between 88,0 and 100,0 %. The plant extract was 
found to have cytotoxic activity with 444,81±2,12 µg/ml IC50 value.This is the first study that involves 
the in vitro antileishmanial activity of B. vulgaris which is wildly growing in Manisa, Turkey. Initial 
results demonstrated that the ethanolic extract of B. vulgaris gave promising results and it could be 
used as an antileishmanial agent in future. 
 
INTRODUCTION 
Berberis vulgaris L. (Barberry, family Berberidaceae) is native to central and southern Europe, 
western Asia and northwest Africa. The root, bark, leaf, fruits of barberry are used in traditional 
medicine. The plant is a shrub, 1–3 m tall, spiny, with yellow wood and small, ovalleaves, bearing 
yellow flowers and red oval fruits (barberry)1-3. 
Medicinal properties for all parts of the plant have been reported, including tonic, antioxidant, 
antimicrobial, antiemetic, antipyretic, antipruritic, anti-inflammatory,antinociceptive, hypotensive, 
antiarrhythmic, anticholinergic, sedative, and cholagogue actions. It has been used in some cases like 
cholecystitis, cholelithiasis, dysentery, leishmaniasis and malaria4. 
The main bioactive components of this plant are reported to be the alkaloids such as berbamine, 
palmatine and particularly berberine1,5. 
Leishmaniasis is a protozoan parasitic disease found in 16 developed and 72 developing countries with 
12 million case6.The cutaneous leishmaniasis (CL), most common type of leishmaniasis was reported 
to be and affecting 1.5 million people annually, worldwide. Over 90% of cases are reported from 
countries such as Afghanistan, Iraq, Pakistan, Iran7.Visceral leishmaniasis (VL) is known to be the 
most severe form of leishmaniasis in the world8. 
  
Plant derived compounds and extracts are known to be valuable sources for the treatment of various 
diseases.The extract prepared from the roots and fruits of Berberis vulgaris were previously reported 
to possess in vitroleishmanicidalactivity against Leishmaniatropicaand L. infantum9,10. 
The aim of the present study was to determine the in vitroantileishmanial efficacy of ethanol extract 
prepared from the aerial parts of Berberis vulgaris collected from Spil Mountain, Manisa, Turkey.In 
addition to in vitroantileishmanial activity against Leishmaniatropica promastigotes, cytotoxic activity 
of the plant extract was also measured using a WST-1 cell proliferation assay11,12. 
 
MATERIAL AND METHODS 
Plant material 
Berberis vulgarisaerial parts are collected from Spil Mountain, Manisa, Turkey. The plant species 
were identified by Dr. CenkDurmuskahya (Izmir KatipCelebi University, Faculty of Forestry, 
Department of Forest Engineering, Balatcik, İzmir Turkey) 
Preparation of plant extract 
The air dried and ground aerial parts of B. vulgaris were extracted in ethanol with stirring at room 
temperature. The extraction yield was determined as 3.6 %. 
Phytochemical analysis of plant extract  
Phytochemical screening tests for plant secondary metabolites such as tannins, terpenoids, flavonoids 
and alkaloids were conducted on plant extract13. 
In vitroantileishmanial assay 
A range of concentrations of the plant extract (25-500µg/mL) were prepared for in vitro 
antileishmanial assays.The haemocytometer counting of living Leishmaniatropica promastigotes in 
RPMI 1640 medium was preferred for in vitro assessments.All the experiments were run in triplicate 
and results were expressed as mean percentage inhibition of parasites. Glucantime was used as a 
reference drug11. 
Determination of Cytotoxic Activities (IC50) of Plant Extract 
The consecutive concentrations of plant extracts within 1 nM-100 μM were prepared and IC50 levels 
were determined by using “xCELLigence Real-Time Cell Analyzer” in 96 hours. A total of 2x106/ml 
cells were distributed for each cell line in the plates having 96 gold-coated wells, including the control 
group without plant extract. Each assessment was run in triplicate. IC50 levels of the plant extracts in 
each cell line were confirmed in a colorimetric fashion with WST1 (4-[3-(4-iodophenyl)-2-(4-
nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) test; following the addition of WST1, all 
extracts were kept for 4 hours inside an incubator with 5 % CO2, and 95 % humidity at 37°C. The 
colorimetric change was determined quantitatively at 450 nm and 600 nm reference intervals by using 
a Multiscan FC Thermo Scientific microplate reader12. 
RESULTS AND DISCUSSION 
The preliminary phytochemical analysis results for the ethanolic extract of aerial parts of B. 
vulgariswere positive for flavonoids, tannins, anthracenes, terpenoids and alkaloids. The cytotoxic 
activity of plant extract was determined against WI-38 foetal lung fibroblast cell linesby real-time 
  
analyser. The plant extract was found to have cytotoxic activity with 444,81±2,12 µg/ml IC50 
value.The number of parasites at different concentrations of the extract and the reference drug 
glucantime was shown in figure 1.Parasite inhibition was observed between 88.0±0.04 and 100±0.00 
% in the presence of B. vulgaris ethanol extract, when measured in comparison with a glucantime-
treated reference group at time intervals of 12-72 hours (Table 1). The plant extract with IC50 value of 
444.81±2.12 µg/ml was not found to be significantly cytotoxic against lung fibroblast cell lines. 
In a previous work on investigation against different Leishmaniaspaecies, the aqueous and methanolic 
extracts of aerial parts of B. vulgaris were reported to have inhibitory activities against L.tropicaand L. 
infantum.Berberine, the biologically active component of B.vulgaris was also reported to have 
significant inhibitory effects on the promastigote and amastigote forms of the mentioned leishmanial 
parasites8. The ethanolicextract prepared from fruits of B. vulgaris were found to be active against 
L.tropicapromastioges and amastigotes with IC50 4.8 and 24.03 µg/ml respectively10. The previous 
studies support our findings and further studies should be conducted. 
CONCLUSION 
This is the first study that involves the assessment in vitro antileishmanial activity of B. vulgaris 
growing wildly in Turkey.Further in vivo studies are required to elucidate the potential mechanism of 
action and identify the structures of compounds responsible for the observed antileishmanial 
activity.The results demonstrated that the ethanolic extract of B. vulgaris is promising and it could be 
used as a source forantileishmanial agents in future. 
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Figure 1.  The parasite counts at different concentrations and time intervals 
 
Table 1. The parasite inhibition percentages of Berberis vulgarisethanolic extracts 
 
 
 
 
 
 
 
 
 
                                 Parasite inhibition % 
12hrs 24hrs 48-72 hrs 
B. vulgaris Ethanol 
Extract (µg/ml) 
   
25 88,00 89,00 89,70 
50 89,00 95,60 96,00 
125 95,90 97,00 96,60 
250 99,30 99,40 99,42 
500 100,00 100,00 100,00 
